Finance

Lists
600420:SHA
Shanghai Shyndec Pharmaceutical Co Ltd
CNÂ¥7.86
-0.76%
(-0.060) 1D
Nov 19, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600420...
Open
CNÂ¥7.93
High
CNÂ¥7.97
Low
CNÂ¥7.85
Mkt. cap
10.62B
Avg. vol.
6.51M
Volume
5.46M
Dividend
3.18%
Quarterly dividend
CNÂ¥0.06
Ex-dividend date
Sep 18, 2026
P/E ratio
23.35
52-wk high
CNÂ¥11.09
52-wk low
CNÂ¥7.67
EPS
CNÂ¥0.34
Shares outstanding
1.06B
No. of employees
10K
Open
CNÂ¥7.93
High
CNÂ¥7.97
Low
CNÂ¥7.85
Mkt. cap
10.62B
Avg. vol.
6.51M
Volume
5.46M
Dividend
3.18%
Quarterly dividend
CNÂ¥0.06
Ex-dividend date
Sep 18, 2026
P/E ratio
23.35
52-wk high
CNÂ¥11.09
52-wk low
CNÂ¥7.67
EPS
CNÂ¥0.34
Shares outstanding
1.06B
No. of employees
10K
News stories
From web sources and news partners
About Shanghai Shyndec Pharmaceutical Co Ltd
CEO-
Employees9.7K
FoundedNov 27, 1996
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
2.44B
2.06B
1.88B
1.65B
Cost of goods sold
1.82B
1.44B
1.36B
1.16B
Cost of revenue
1.82B
1.44B
1.36B
1.16B
Research and development expenses
105.95M
78.82M
87.14M
92.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
399.48M
278.47M
278.02M
294.74M
Operating expense
563.58M
374.72M
377.27M
353.27M
Total operating expenses
2.38B
1.82B
1.74B
1.51B
Operating income
57.91M
248.68M
136.68M
133.91M
Other non operating income
-20.75M
-12.37M
9.92M
-39.45M
EBT including unusual items
212.10M
248.32M
194.78M
80.49M
EBT excluding unusual items
111.77M
270.29M
146.61M
154.71M
Income tax expense
3.16M
56.18M
23.69M
13.17M
Effective tax rate
1.49%
22.62%
12.16%
16.36%
Other operating expenses
59.46M
8.61M
13.63M
-31.75M
Net income
140.43M
138.40M
137.19M
35.40M
Net profit margin
5.75%
6.70%
7.31%
2.15%
Earnings per share
-
-
-
-
Interest and investment income
72.55M
34.52M
24.50M
36.69M
Interest expense
-223.56K
-538.23K
-490.94K
-447.63K
Net interest expenses
72.32M
33.98M
24.01M
36.24M
Depreciation and amortization charges
-
-
-
-
EBITDA
232.56M
423.32M
315.65M
308.55M
Gain or loss from assets sale
2.65M
-
557.24K
-557.24K
Upcoming events
AI content may include mistakes. Learn more
Google apps